(Total Views: 287)
Posted On: 05/08/2019 1:30:40 PM
Post# of 154849

$CYDY News Article - CytoDyn Provides Updated Pre-Clinical Data Showing Leronlimab (PRO 140) Continues to Suppress Breast Cancer Metastatic Burden >98% Compared with Untreated Animals https://marketwirenews.com/news-releases/cyto...42928.html


My Twitter: WhyteStocks